20 (AIDX) Change in Account Payables (2025 - 2026)
20's (AIDX) quarterly Change in Account Payables came in at $111941.0 in Q1 2026, up 0.76% YoY from $111092.0 in Q1 2025, and up 0.76% on a QoQ basis from $111092.0 in Q1 2025.
20 (AIDX) Change in Account Payables (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Change in Account Payables data on file, last reported at $111941.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | 20 | 6.00 Mn | 1.45 Mn | 304,727.00 | 46,324.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111,941.00 |
| Mar 31, 2026 | 111,941.00 |
| Mar 31, 2025 | 111,092.00 |
| Mar 31, 2025 | 111,092.00 |